Press Releases

Eisai Co., Ltd. announced that its in-house discovered and developed antiepileptic drug (AED) perampanel , for which a NDA was submitted for review as an adjunctive treatment for partial onset seizures in epilepsy patients 12 years of age and...

Eisai Co., Ltd. announced that its in-house discovered and developed antiepileptic drug (AED) perampanel , for which a NDA was submitted for review as an adjunctive treatment for partial onset seizures in epilepsy patients 12 years of age and...

North Estonia Medical Centre (NEMC) consists of seven clinics and 32 specialist centers, and is the most important caregiver in the capital of Estonia, Tallinn, as well as in the northern part of the country. As...

Turkish Cargo organized a Special event titled 'Turkish Cargo & IATA CEIV Pharma Workshop’ for the leading pharmaceutical companies, officials from IATA, agents and business partners. Providing service to 124 countries around the world as one of the fastest growing...

Monoclonal antibodies (MAbs) have been extraordinary tools in the field of bioscience due to their high level of specificity and selective binding ability. Besides its applications in diagnostics, such as the identification of cell surface markers...

Swedish life science company, OnDosis, and global contract development and manufacturing organisation (CDMO), Recipharm, have entered into an agreement for the formulation development of an ADHD treatment for the US market. The new treatment for the...

Axol Bioscience, the human cell culture specialist, is launching a new line of Human induced Pluripotent Stem Cells (iPSC)-derived Microglia for the consistent and reproducible study of neuroglia and their involvement in neurodegenerative diseases, including Alzheimer’s disease, multiple sclerosis...